Guidance

Reporting adverse incidents: cardiac implantable electronic devices (CIEDs)

Guidance for manufacturers reporting adverse incidents with these devices under the European vigilance system.

From:
Medicines and Healthcare products Regulatory Agency
Published
6 August 2020

This publication was withdrawn on

Withdrawn due to the end of the Brexit transition period. Please see: https://ec.europa.eu/docsroom/documents/37283

Documents

European Commission’s guidance on reporting incidents with cardiac implantable electronic devices

HTML

Details

You need to read this alongside the European Commission’s guidelines on the vigilance system for medical devices

Updates to this page

Published 6 August 2020

Sign up for emails or print this page

Related content